18 June 2013
Keywords: medigene, takes, over, firm, neurovir, german, biopharmaceutical
Article | 10 November 2000
German biopharmaceutical company MediGene AG has signed an acquisitionagreement with the San Diego, USA-based NeuroVir Therapeutics, which develops herpes simplex ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.